To investigate Ninj1’s role in atherosclerosis, we synthesized mPN12, a competitive inhibitory peptide targeting Ninj1’s adhesion domain (Pro26-Asn37) and evaluated its effects on plaque development in ApoE−/− mice. This evidence concerns the gene APOE and atherosclerosis.